Literature DB >> 17553010

Role of cortical cannabinoid CB1 receptor in conditioned taste aversion memory.

Tali Kobilo1, Shoshi Hazvi, Yadin Dudai.   

Abstract

The brain endocannabinoid system has been shown to play a role in memory, though the extent to which this role generalizes over different types and processes of memory is not yet determined. Here we show that the cannabinoid receptor 1 (CB1) plays differential roles in acquisition, extinction and reconsolidation of conditioned taste aversion (CTA) memory in the rat insular cortex, which contains the taste cortex. Activation of the CB1 receptor in the insular cortex inhibits acquisition and reconsolidation but not extinction, whereas blockade of the CB1 receptor promotes memory and blocks extinction of CTA, while having no apparent effect on reconsolidation. The CB1 ligands used in this study were incapable of substituting the unconditioned stimulus in CTA training. All in all, the data raise the possibility that the state of activity of the CB1 receptor in the insular cortex contributes to the encoding of hedonic valence that enters into association with taste items.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17553010     DOI: 10.1111/j.1460-9568.2007.05561.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  17 in total

Review 1.  The endocannabinoid system and extinction learning.

Authors:  Beat Lutz
Journal:  Mol Neurobiol       Date:  2007-08-17       Impact factor: 5.590

2.  Activation of LVGCCs and CB1 receptors required for destabilization of reactivated contextual fear memories.

Authors:  Akinobu Suzuki; Takuya Mukawa; Akinori Tsukagoshi; Paul W Frankland; Satoshi Kida
Journal:  Learn Mem       Date:  2008-05-29       Impact factor: 2.460

3.  Cannabinoid reward and aversion effects in the posterior ventral tegmental area are mediated through dissociable opiate receptor subtypes and separate amygdalar and accumbal dopamine receptor substrates.

Authors:  Tasha Ahmad; Steven R Laviolette
Journal:  Psychopharmacology (Berl)       Date:  2017-07-01       Impact factor: 4.530

Review 4.  Psychedelics and reconsolidation of traumatic and appetitive maladaptive memories: focus on cannabinoids and ketamine.

Authors:  Liana Fattore; Alessandro Piva; Mary Tresa Zanda; Guido Fumagalli; Cristiano Chiamulera
Journal:  Psychopharmacology (Berl)       Date:  2017-11-25       Impact factor: 4.530

5.  Role of the agranular insular cortex in contextual control over cocaine-seeking behavior in rats.

Authors:  Amy A Arguello; Rong Wang; Carey M Lyons; Jessica A Higginbotham; Matthew A Hodges; Rita A Fuchs
Journal:  Psychopharmacology (Berl)       Date:  2017-05-02       Impact factor: 4.530

6.  On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment.

Authors:  Cristina A J Stern; Lucas Gazarini; Reinaldo N Takahashi; Francisco S Guimarães; Leandro J Bertoglio
Journal:  Neuropsychopharmacology       Date:  2012-05-02       Impact factor: 7.853

7.  Effects of cannabinoid CB1 receptor antagonist rimonabant in consolidation and reconsolidation of methamphetamine reward memory in mice.

Authors:  Lu-lu Yu; Xue-yi Wang; Mei Zhao; Yu Liu; Yan-qin Li; Fang-qiong Li; Xiaoyi Wang; Yan-xue Xue; Lin Lu
Journal:  Psychopharmacology (Berl)       Date:  2009-01-16       Impact factor: 4.530

8.  Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance.

Authors:  Eti Ganon-Elazar; Irit Akirav
Journal:  J Neurosci       Date:  2009-09-09       Impact factor: 6.167

9.  Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats.

Authors:  Cristiane Ribeiro De Carvalho; Fabrício Alano Pamplona; Jéssica Silveira Cruz; Reinaldo Naoto Takahashi
Journal:  Psychopharmacology (Berl)       Date:  2013-11-19       Impact factor: 4.530

10.  The CB1 receptor antagonist AM251 impairs reconsolidation of pavlovian fear memory in the rat basolateral amygdala.

Authors:  Patrizia Ratano; Barry J Everitt; Amy L Milton
Journal:  Neuropsychopharmacology       Date:  2014-05-07       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.